| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,711 |
5,941 |
$409K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
1,102 |
715 |
$123K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,274 |
2,366 |
$97K |
| 99215 |
Prolong outpt/office vis |
1,525 |
973 |
$79K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,492 |
1,225 |
$57K |
| Q3014 |
Telehealth originating site facility fee |
2,644 |
2,101 |
$53K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
579 |
477 |
$48K |
| 99205 |
Prolong outpt/office vis |
358 |
273 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
709 |
385 |
$17K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
399 |
336 |
$15K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
316 |
179 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
145 |
$4K |
| 99218 |
|
73 |
60 |
$3K |
| 99490 |
Ccm add 20min |
220 |
173 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
149 |
126 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
72 |
62 |
$2K |
| 90674 |
|
194 |
141 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
870 |
673 |
$2K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
13 |
13 |
$2K |
| 82075 |
|
644 |
422 |
$1K |
| 80306 |
|
602 |
409 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
214 |
171 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
88 |
83 |
$863.37 |
| 99217 |
|
17 |
14 |
$609.18 |
| 99407 |
|
82 |
57 |
$85.54 |
| 80305 |
|
50 |
36 |
$44.88 |
| 81025 |
|
32 |
24 |
$32.40 |
| 90686 |
|
105 |
92 |
$30.30 |
| 99000 |
|
102 |
101 |
$0.00 |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
18 |
18 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
42 |
23 |
$0.00 |
| 99401 |
|
19 |
16 |
$0.00 |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
18 |
15 |
$0.00 |
| H2011 |
Crisis intervention service, per 15 minutes |
21 |
18 |
$0.00 |
| 90756 |
|
17 |
14 |
$0.00 |